×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
RAPP – rapport therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
RAPP
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/23
08:12 am
rapp
Rapport Therapeutics (RAPP) had its "buy" rating reaffirmed by BTIG Research. They now have a $53.00 price target on the stock.
Medium
Report
Rapport Therapeutics (RAPP) had its "buy" rating reaffirmed by BTIG Research. They now have a $53.00 price target on the stock.
4/21
04:30 pm
rapp
Rapport Therapeutics Presents RAP-219 Focal Onset Seizure Phase 2a Follow-up Period Results Demonstrating Sustained Seizure Reduction at the 2026 American Academy of Neurology Annual Meeting
Low
Report
Rapport Therapeutics Presents RAP-219 Focal Onset Seizure Phase 2a Follow-up Period Results Demonstrating Sustained Seizure Reduction at the 2026 American Academy of Neurology Annual Meeting
4/11
05:32 am
rapp
Rapport Therapeutics (RAPP) was upgraded by Raymond James Financial, Inc. to "strong-buy".
Low
Report
Rapport Therapeutics (RAPP) was upgraded by Raymond James Financial, Inc. to "strong-buy".
4/10
09:00 am
rapp
Rapport Therapeutics (RAPP) is now covered by Raymond James Financial, Inc.. They set a "strong-buy" rating and a $66.00 price target on the stock.
Low
Report
Rapport Therapeutics (RAPP) is now covered by Raymond James Financial, Inc.. They set a "strong-buy" rating and a $66.00 price target on the stock.
4/1
07:00 am
rapp
Rapport Therapeutics to Present New Phase 2 Treatment Follow-Up Data for RAP-219 in Focal Onset Seizures at the 2026 American Academy of Neurology Annual Meeting
Low
Report
Rapport Therapeutics to Present New Phase 2 Treatment Follow-Up Data for RAP-219 in Focal Onset Seizures at the 2026 American Academy of Neurology Annual Meeting
3/27
06:17 am
rapp
All You Need to Know About Rapport Therapeutics, Inc. (RAPP) Rating Upgrade to Buy [Yahoo! Finance]
Medium
Report
All You Need to Know About Rapport Therapeutics, Inc. (RAPP) Rating Upgrade to Buy [Yahoo! Finance]
3/26
05:49 am
rapp
Rapport Therapeutics (RAPP) was upgraded by Truist Financial Corporation to "strong-buy".
Low
Report
Rapport Therapeutics (RAPP) was upgraded by Truist Financial Corporation to "strong-buy".
3/20
08:35 pm
rapp
How Investors May Respond To Rapport Therapeutics (RAPP) Licensing RAP-219 To Tenacia In Greater China [Yahoo! Finance]
Low
Report
How Investors May Respond To Rapport Therapeutics (RAPP) Licensing RAP-219 To Tenacia In Greater China [Yahoo! Finance]
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/23
07:37 am
rapp
Form ARS Rapport Therapeutics, For: Dec 31
Low
Report
Form ARS Rapport Therapeutics, For: Dec 31
4/23
07:25 am
rapp
Form DEFA14A Rapport Therapeutics,
Low
Report
Form DEFA14A Rapport Therapeutics,
4/23
07:20 am
rapp
Form DEF 14A Rapport Therapeutics, For: Jun 10
Low
Report
Form DEF 14A Rapport Therapeutics, For: Jun 10
4/21
07:36 pm
rapp
Form 4 Rapport Therapeutics, For: Apr 17 Filed by: TRV GP VI, LLC
Low
Report
Form 4 Rapport Therapeutics, For: Apr 17 Filed by: TRV GP VI, LLC
4/21
04:55 pm
rapp
Form 4 Rapport Therapeutics, For: Apr 17 Filed by: Yeleswaram Krishnaswamy
Low
Report
Form 4 Rapport Therapeutics, For: Apr 17 Filed by: Yeleswaram Krishnaswamy
4/21
04:51 pm
rapp
Form 8-K Rapport Therapeutics, For: Apr 21
Low
Report
Form 8-K Rapport Therapeutics, For: Apr 21
4/17
04:38 pm
rapp
Form 144 Rapport Therapeutics, Filed by: Yeleswaram Krishnaswamy
Medium
Report
Form 144 Rapport Therapeutics, Filed by: Yeleswaram Krishnaswamy
4/14
04:14 pm
rapp
Form 4 Rapport Therapeutics, For: Apr 10 Filed by: Yeleswaram Krishnaswamy
Low
Report
Form 4 Rapport Therapeutics, For: Apr 10 Filed by: Yeleswaram Krishnaswamy
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: